Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Classifica tra le azioni #478
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Prezzo delle azioni
$19.63
Capitalizzazione di mercato
$47.10B
Variazione (1 giorno)
1.80%
Variazione (1 anno)
-7.33%
Paese
IN
Scambia Sun Pharmaceutical Industries Limited (SUNPHARMA)

Categoria

Ricavi di Sun Pharmaceutical Industries Limited (SUNPHARMA)
Ricavi nel Dec 2025 TTM: $6.31B
Secondo gli ultimi rapporti finanziari di Sun Pharmaceutical Industries Limited, i ricavi attuali dell'azienda (TTM) sono pari a $6.31B. Nel 2024, l'azienda ha registrato ricavi di $5.82B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $5.34B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Sun Pharmaceutical Industries Limited da 2004 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $6.31B 2.69%
2025 $6.15B 5.70%
2024 $5.82B 8.91%
2023 $5.34B 4.87%
2022 $5.09B 11.28%
2021 $4.58B 4.98%
2020 $4.36B 4.14%
2019 $4.19B 3.17%
2018 $4.06B -15.97%
2017 $4.83B 13.79%
2016 $4.24B -3.35%
2015 $4.39B 63.63%
2014 $2.68B 29.00%
2013 $2.08B 31.80%
2012 $1.58B 22.91%
2011 $1.28B 47.70%
2010 $869.23M 3.29%
2009 $841.54M 0.33%
2008 $838.79M 70.54%
2007 $491.84M 33.83%
2006 $367.50M 33.92%
2005 $274.42M 20.98%
2004 $226.82M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$4.43B -29.76%
FR
$24.76B 292.14%
DE
$28.60B 352.97%
JP
$9.47B 49.96%
US
$25.92B 310.58%
GB